Skip to content

    Our partner Noze amplifies fight against tuberculosis with new grant

    MONTREAL, March 28, 2024 /PRNewswire/ — Canadian-based Noze, a global leader in the breath-based diagnostic space, announced today it received a new grant from the Bill & Melinda Gates Foundation, bringing the foundation’s total grant funding to Noze to $1.8 million. The announcement comes on the heels of World Tuberculosis Day, which was recognized on March 24th.

    The grant will fund a groundbreaking clinical study aimed at detecting tuberculosis (TB) in high-burden countries, using the company’s DiagNoze® — a handheld breathalyzer designed for the real-time detection and screening of various medical conditions, including infectious diseases such as TB. The cost-effective and rapid results offered by DiagNoze® are poised to shorten the time to diagnosis, facilitate earlier intervention, and significantly improve patient outcomes. Ultimately, the goal is for Noze to help enable universal access and play a vital role in the global fight against the spread of TB.

    “We’re thrilled to receive additional funding from the Bill & Melinda Gates Foundation. This new grant will support Noze’s capacity to profoundly influence the management and eradication of infectious diseases,” noted Karim Aly, CEO of Noze.